Stay updated on Atezolizumab in High-Risk Bladder Cancer Clinical Trial
Sign up to get notified when there's something new on the Atezolizumab in High-Risk Bladder Cancer Clinical Trial page.

Latest updates to the Atezolizumab in High-Risk Bladder Cancer Clinical Trial page
- Check5 days agoChange DetectedNew entries add Contacts/Locations, Outcome Measures, Arms and Interventions, Study Design, Oversight, and Study Status with version 2026-03-24. An older item was deleted on 2026-02-13.SummaryDifference0.4%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedA new revision entry (v3.5.0) was added to the record history and an older revision (v3.4.3) was removed.SummaryDifference0.0%

- Check26 days agoChange DetectedA new revision entry v3.4.3 was added to the history, and the previous entry v3.4.2 was removed.SummaryDifference0.0%

- Check48 days agoChange DetectedVersion 61 (2026-02-13) adds Contacts/Locations and Study Status to the record history. A prior entry from 2026-01-14 was removed.SummaryDifference0.2%

- Check55 days agoChange DetectedAn administrative update adds Revision: v3.4.2 and removes older notices (lapse-in-funding notice and v3.4.1 reference). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check62 days agoChange DetectedA government funding notice was added and the page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.4%

Stay in the know with updates to Atezolizumab in High-Risk Bladder Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Atezolizumab in High-Risk Bladder Cancer Clinical Trial page.